IM HealthScience (IMH) is a privately held company based in Boca Raton, Florida. It was founded in 2013 by a team of highly experienced pharmaceutical research and development and management executives. The company is dedicated to developing products to address overall health and wellness, including conditions with a high unmet medical need.

IMH is the innovator of IBgard® and FDgard® for the dietary management of IBS (Irritable Bowel Syndrome) and FD (Functional Dyspepsia), respectively. In 2017, IMH added Fiber Choice®, a line of prebiotic fibers, to its product line via an acquisition. The sister subsidiary of IMH, Physician’s Seal®, provides REMfresh®, a well-known continuous release and absorption melatonin (CRA-melatonin) supplement for sleep. IMH co-markets REMfresh with Physician’s Seal.

IM HealthScience seeks exceptional people who aspire to execute with excellence, who take pride in building something new and who genuinely care about people.
IMH firmly believes that medical foods can improve the lives of patients for whom dietary and lifestyle changes are not enough.
IMH firmly believes that dietary supplements can improve the lives of patients for whom dietary and lifestyle changes are not enough.